Before the treatments, 5-HT4R expressions in each IBS subtype showed no significant difference in the EA and Mox group (P = 0.574, 0.189, 0.610 for IBS-D, IBS-C, and IBS-A/M, resp., all P > 0.05). This evidence concerns the gene HTR4 and irritable bowel syndrome.